Viemed enters $60M senior secured credit facilities with accordion up to $90M

VIEMED HEALTHCARE, INC.

New facilities: $30M revolving credit facility (5-yr) + $30M delayed draw term loan (5-yr), total $60M.
Accordion feature allows increase by up to $30M, total borrowing capacity up to $90M.
Previous $10M line of credit and $4.7M term note retired upon closing.
Interest rate: Term SOFR + 2.625%-3.375% or Base Rate + 1.625%-2.375%.
Lending group: Regions (agent), Hancock Whitney, Fifth Third; proceeds for M&A, WC, capex.

item 1.01 item 1.02 item 2.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VIEMED HEALTHCARE, INC. entered into Credit Agreement with Regions Bank, as administrative agent, and the lenders from time to time party thereto valued at up to $60 million (effective 2022-11-29).

Action: entry
Agreement: credit facility
Counterparty: Regions Bank, as administrative agent, and the lenders from time to time party thereto
Value: up to $60 million
Effective: 2022-11-29

Exact text from the filing

On November 29, 2022 (the “ Closing Date ”), Viemed, Inc. (the “ Borrower ”), and certain subsidiaries of the Borrower, as guarantors (the “ Guarantors ” and together with the Borrower, the “ Credit Parties ”), all wholly-owned subsidiaries of Viemed Healthcare, Inc. (the “ Company ”), entered into that certain credit agreement (the “ Credit Agreement ”) with the lenders from time to time party thereto (the “ Lenders ”) and Regions Bank, as administrative agent (the “ Administrative Agent ”) and collateral agent (the “ Collateral Agent ”).

View on SEC.gov

Browse all material agreements →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-22-000106

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.